[go: up one dir, main page]

AU7335396A - Membrane-fusible liposome with the use of recombinant sendai virus - Google Patents

Membrane-fusible liposome with the use of recombinant sendai virus

Info

Publication number
AU7335396A
AU7335396A AU73353/96A AU7335396A AU7335396A AU 7335396 A AU7335396 A AU 7335396A AU 73353/96 A AU73353/96 A AU 73353/96A AU 7335396 A AU7335396 A AU 7335396A AU 7335396 A AU7335396 A AU 7335396A
Authority
AU
Australia
Prior art keywords
membrane
sendai virus
recombinant sendai
fusible
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73353/96A
Inventor
Mamoru Hasegawa
Atsushi Kato
Yoshiyuki Magai
Fukashi Murai
Yosuke Suzuki
Katsuo Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dnavec Research Inc
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Publication of AU7335396A publication Critical patent/AU7335396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU73353/96A 1995-11-01 1996-10-22 Membrane-fusible liposome with the use of recombinant sendai virus Abandoned AU7335396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30825295 1995-11-01
JP7-308252 1995-11-01
PCT/JP1996/003070 WO1997016171A1 (en) 1995-11-01 1996-10-22 Membrane-fusible liposome with the use of recombinant sendai virus

Publications (1)

Publication Number Publication Date
AU7335396A true AU7335396A (en) 1997-05-22

Family

ID=17978777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73353/96A Abandoned AU7335396A (en) 1995-11-01 1996-10-22 Membrane-fusible liposome with the use of recombinant sendai virus

Country Status (3)

Country Link
JP (1) JP3992200B2 (en)
AU (1) AU7335396A (en)
WO (1) WO1997016171A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
ATE399206T1 (en) * 1999-05-18 2008-07-15 Dnavec Research Inc RIBONUCLEOPROTEIN COMPLEX FROM PARAMYXOVIRUS
EP1186667B1 (en) * 1999-05-18 2007-07-18 Dnavec Research Inc. Envelope gene-deficient virus vector of paramyxoviridae
JP4838962B2 (en) * 1999-11-02 2011-12-14 株式会社ディナベック研究所 Recombinant Sendai virus vector for exogenous gene transfer into airway epithelial cells
JPWO2003092738A1 (en) * 2002-04-30 2005-09-08 株式会社ディナベック研究所 Drug or gene delivery composition with reduced hemagglutinin activity
JPWO2007049752A1 (en) 2005-10-28 2009-04-30 ディナベック株式会社 Gene transfer into airway epithelial stem cells using lentiviral vectors pseudotyped with RNA or DNA virus spike proteins
EP2738255B1 (en) 2011-07-29 2016-11-23 Tokushima University Erap1-derived peptide and use thereof
EP3889264A4 (en) 2018-11-30 2022-10-12 Tokushima University BREAST CANCER THERAPEUTIC WITH BIG3-PHB2 INTERACTION INHIBITING PEPTIDE FROM PHB2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses

Also Published As

Publication number Publication date
JP3992200B2 (en) 2007-10-17
WO1997016171A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
AU9397098A (en) Methods and cell line useful for production of recombinant adeno-associated viruses
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
AU5801296A (en) Crosslinkable polypeptide compositions
AU4273097A (en) Headband with dual material construction
AU3119895A (en) Recombinant virus vectors
AU5827896A (en) Inhaler with collapsible chamber
AU2705395A (en) Fas associated proteins
AU9222698A (en) Novel molecules of the tnfr-ligand-related protein family and uses thereof
AU4689596A (en) Anti-inflammatory cd14 peptides
AU5320296A (en) Modified viral envelope polypeptide
AU6299594A (en) Recombinant fowlpox virus s-fpv-043 and uses thereof
AU1099597A (en) Novel xylanases and uses thereof
AU7335396A (en) Membrane-fusible liposome with the use of recombinant sendai virus
AUPO026596A0 (en) Viral peptide
AU2131195A (en) Prophenins - antibiotic peptides
AU1991799A (en) Molecules associated with the human suppressor of fused gene
AU5652396A (en) Glucose-inducible recombinant viral vector
AU6715094A (en) Recombinant vaccine
AU3288497A (en) Mammalian tolloid-like gene and protein
AU5550296A (en) Conotoxin peptides
AU5293198A (en) Promoter of the human endoglin gene and its use
AU2168795A (en) Recombinant Gibberellin DNA and uses thereof
AUPM489194A0 (en) Peptides
AU1954995A (en) Viral replicon
AU6087694A (en) The l-plastin promoter region and its uses